Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of June 2026
Charlene Vos @Charlene Vos
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,438,810talents

Virtual portfolio value:

$5,371,940talents

Net overall return per annum:

19.39%

AYA current rank order:

#4

Asset investment philosophy:
Charlene Vos trades U.S. stocks with the top #26 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 32,466 +2,108.33% $246,417
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 41,969 +833.33% $125,907
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 41,969 +833.33% $125,907
UMAC Unusual Machines Inc. Common Stock $1.87 $18.73 7,344 +901.60% $123,820
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 88,993 +793.33% $105,902
XBIOW Xenetic Biosciences Inc. Warrants $2.00 $23.16 4,611 +1,058.00% $97,569
VATE INNOVATE Corp. Common Stock $0.53 $4.14 25,186 +681.13% $90,921
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 696 +601.88% $77,875
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,167 +660.87% $49,408
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,161 +589.24% $47,682
Sum $1,091,408

Top 10 current stock portfolio positions as of June 2026Strategy

Symbol Company Price Position Capitalization
NVCT Nuvectis Pharma Inc. Common Stock $27.19 3,038 $82,603
QURE uniQure N.V. Ordinary Shares $47.51 1,038 $49,315
MBX MBX Biosciences Inc. Common Stock $52.31 941 $49,223
AMAT Applied Materials Inc. Common Stock $626.84 65 $40,744
TECH Bio-Techne Corp Common Stock $71.00 573 $40,683
MGNI Magnite Inc. Common Stock $18.73 2,067 $38,714
LGND Ligand Pharmaceuticals Incorporated Common Stock $303.59 127 $38,555
HIMS Hims & Hers Health Inc. Class A Common Stock $33.94 1,133 $38,454
WRLD World Acceptance Corporation Common Stock $213.77 179 $38,264
TCI Transcontinental Realty Investors Inc. Common Stock $49.85 764 $38,085
Sum $454,640

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Blog+More

President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries.

Charlene Vos

2018-05-07 07:32:00 Monday ET

President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries.

President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri

+See More

OraSure and its subsidiary DNA Genotek specialize in the lean production of home DNA spit tubes.

Monica McNeil

2019-04-01 08:28:00 Monday ET

OraSure and its subsidiary DNA Genotek specialize in the lean production of home DNA spit tubes.

OraSure and its subsidiary DNA Genotek specialize in the lean production of home DNA spit tubes. OraSure extracts core genetic information from microbiome s

+See More

What are the best online stock market investment tools?

Amy Hamilton

2021-07-07 05:22:00 Wednesday ET

What are the best online stock market investment tools?

What are the best online stock market investment tools? Stock trading has seen an explosion since the start of the pandemic. As people lost their jobs an

+See More

The Trump $1.5 trillion hefty tax cuts and $1 trillion infrastructure expenditures may speed up the Federal Reserve interest rate hike.

Joseph Corr

2018-03-15 07:41:00 Thursday ET

The Trump $1.5 trillion hefty tax cuts and $1 trillion infrastructure expenditures may speed up the Federal Reserve interest rate hike.

The Trump administration's $1.5 trillion hefty tax cuts and $1 trillion infrastructure expenditures may speed up the Federal Reserve interest rate hike

+See More

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America.

Joseph Corr

2019-09-05 09:26:00 Thursday ET

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America.

Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America. Firs

+See More

Artificial intelligence continues to push boundaries for tech titans to sustain their disruptive innovations and competitive advantages.

Chanel Holden

2020-11-01 11:21:00 Sunday ET

Artificial intelligence continues to push boundaries for tech titans to sustain their disruptive innovations and competitive advantages.

Artificial intelligence continues to push boundaries for several tech titans to sustain their central disruptive innovations, competitive moats, and first-m

+See More